Catenae Innovation's Guy Meyer (LON:CTEA) and BHA Medical's Gavyn Hough talks to Proactive London after the announcement of their joint venture to deliver an integrated COVID-19 test.

Meyer believes this partnership is strategically aligned and both counterparts complement each other's offering, with Catenae providing the technology part of this team.

Hough explains their global role and in supplying 350,000 kits to date to FTSE 100 companies. He says: 'We have the science, they have the technology and as a solution that is a match made in heaven'.

Attachments

  • Original document
  • Permalink

Disclaimer

Catenae Innovation plc published this content on 16 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 October 2020 17:14:00 UTC